Intercell and GSK in Alliance for Novel Patch Vaccines
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)
Published: 21 Dec-2009
DOI: 10.3833/pdr.v2009.i12.1289 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlaxoSmithKline (GSK) Biologicals SA and Austrian vaccine maker Intercell announced an agreement for a strategic alliance to develop and commercialise innovative needle-free patch-based vaccines...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018